4Peleg AY, Seifert H . Paterson DL. Acinetobacter baumannii Emergence of a Successful Pathogen[J]. Clin Microbiol Rev, 2008,21(3) :538- 582.
5Mugnier PD, Prirel L, Naas T, et al. Worldwide Dissemination of the blaOXA 23 Carbapenemase Gene of Acinetobacter bau rnannii [J]. Emerging Infectious Diseases, 2010,16 ( 1 ) : 35 -40.
6Bennett PM. Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria[J]. British Journal of Pharmacology, 2008,153 :S347-S357.
7Heritier C, Poirel L, Nordmann P. Cephalosporinase overexpression resulting from insertion of ISAbal in Acinetobacter baumannii[J]. Clin Microbiol Infect, 2006,12(6) : 123-130.
8Figueiredo S,Poirel L,Croize J,et al. In Vivo Selection of Re dtlced Susceptibility to Carbapenems in Acinetobacter baumannil Related to ISAba1-Mediated Overexpression of the Natural blaOXA-66 Oxacillinase Gene[J]. Antimicrob Agents Chemother,2009,53(6) :2657-2659.
9Ruzin A,Keeney D,Bradford. AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus Acinetobacter baumannii complex [J]. J Antimicrobial Chemother, 2007,59(5) : 1001-1004.
